Medicines / Companies / Boehringer Ingelheim
Boehringer IngelheimWhat it sells in India.
Boehringer Ingelheim has 22 packs of 11 brands on NPPA's price list for July 2026, across 11 molecules and combinations.
- Packs
- 22
- Brands
- 11
- Molecules
- 11
- Price-controlled packs
- 3
- Failed batches named
- 1 since Aug 2022
Largest molecules
- Linagliptin + Metformin3 packs
- Empagliflozin + Metformin3 packs
- Dabigatran3 packs
- Afatinib3 packs
- Empagliflozin2 packs
- Empagliflozin + Linagliptin2 packs
- Alteplase2 packs
- Linagliptin1 pack
- Tenecteplase1 pack
- Nintedanib1 pack
- Idarucizumab1 pack
Brands
Batches declared not of standard quality
1 batch where a CDSCO alert names this company as the manufacturer. An alert concerns one batch and one test; it is not a finding about the company's other products.
- Aug 2022Ondero Met 2.5mg /500 mg (Fixed Dose Combination of Linagliptin and Metformin Hydrochloride Tablets) · batch C99671Boehringer Ingelheim India Private Limited (Maharashtra, 421302) · Failed: Dissolution, active ingredient degradation and Assay of Linagliptin · CDL Kolkata
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.